Skip to main content

Advertisement

Log in

Enigmatic sex disparities in cancer incidence

  • CANCER
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

In this study we aimed to identify cancers where there is a consistent sex disparity, with the goal of identifying unexplained sex disparities that may offer promising opportunities for etiologic research. Age- and sex-specific cancer incidence data from Cancer Incidence in Five Continents, provided by the International Agency for Research on Cancer, were used to calculate incidence rate ratios for 35 cancer sites, comparing men to women, adjusting for attained age, gross domestic product (GDP), and geographical region. Genital cancers and breast cancer were excluded. The consistency of relative risks was examined by GDP and geographical region and, in a subset of longstanding cancer registers, by calendar year. For each cancer site, the sex disparity was broadly classified as plausibly explained by established environmental risk factors, partly explained, or unexplained. Cancer incidence was statistically significantly higher in men than women at 32 of 35 sites, with disparities >2-fold for 15 sites and >4-fold for 5 sites. For nearly all sites, the sex disparity was consistent across GDP groups and geographical regions. However, the incidence rate ratios varied considerably by age at diagnosis. The sex disparity for 13 cancer sites was considered to be entirely unexplained by known risk factors; these sites showed strikingly little variation in the incidence rate ratios over decades. Thus, the basis of many of the largest sex disparities in cancer incidence seems mostly unknown, highlighting the need for intensified research into its origins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. 2nd ed. New York: Oxford University Press; 2008.

    Google Scholar 

  2. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–82.

    Article  PubMed  Google Scholar 

  3. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629–37.

    Article  PubMed  Google Scholar 

  4. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med. 1995;333(1):32–41.

    Article  PubMed  CAS  Google Scholar 

  5. Czene K, Adami HO, Chang ET. Sex- and kindred-specific familial risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2496–9.

    Article  PubMed  Google Scholar 

  6. Schwartz EE, Upton AC. Factors influencing the incidence of leukemia: special consideration of the role of ionizing radiation. Blood. 1958;13(9):845–64.

    PubMed  CAS  Google Scholar 

  7. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12(6):421–9.

    Article  PubMed  Google Scholar 

  8. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003;12(2):144–50.

    PubMed  Google Scholar 

  9. Gitschier J, Wood WI, Goralka TM, et al. Characterization of the human factor VIII gene. Nature. 1984;312(5992):326–30.

    Article  PubMed  CAS  Google Scholar 

  10. Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(8):686–91.

    Article  PubMed  Google Scholar 

  11. Curado MP, Edwards B, Shin HR, et al., editors. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007.

    Google Scholar 

  12. World Development Indicators [database on the Internet]. The World Bank. 2009. Available from: http://data.worldbank.org/.

  13. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45(Suppl 2):S3–9.

    Article  PubMed  Google Scholar 

  14. MacKay J, Eriksen M. The tobacco atlas. Geneva: World Health Organization; 2002.

    Google Scholar 

  15. IARC monographs on the evaluation of carcinogenic risks to humans: tobacco smoke and involuntary smoking. Lyon: International Agency for Research on Cancer; 2002.

  16. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer. 2001;85(11):1700–5.

    Article  PubMed  CAS  Google Scholar 

  17. IARC monographs on the evaluation of carcinogenic risks to humans: alcohol drinking. Lyon: International Agency for Research on Cancer; 1988.

  18. Driscoll T, Steenland K, Prüss-Üstun A, Imel Nelson D, Leigh J. Occupational carcinogens: assessing the environmental burden of disease at national and local levels. Prüss-Üstün A, Campbell-Lendrum D, Corvalán C, Woodward A, editors. Geneva: World Health Organization; 2004.

  19. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33(7):1075–107.

    Article  PubMed  CAS  Google Scholar 

  20. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777–80.

    Article  PubMed  CAS  Google Scholar 

  21. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985;39(Suppl 1):5–41.

    PubMed  Google Scholar 

  22. Albanes D, Winick M. Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst. 1988;80(10):772–4.

    Article  PubMed  CAS  Google Scholar 

  23. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med. 2010;61:301–16.

    Article  PubMed  CAS  Google Scholar 

  24. IARC monographs on the evaluation of carcinogenic risks to humans: combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. Lyon: International Agency for Research on Cancer; 2005.

  25. Liu J, Morgan M, Hutchison K, Calhoun VD. A study of the influence of sex on genome wide methylation. PLoS One. 2010;5(4):e10028.

    Article  PubMed  Google Scholar 

  26. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008;299(24):2877–83.

    Article  PubMed  CAS  Google Scholar 

  27. Kaminsky ZA, Tang T, Wang SC, et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet. 2009;41(2):240–5.

    Article  PubMed  CAS  Google Scholar 

  28. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8):e1000602.

    Article  PubMed  Google Scholar 

  29. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA. 2005;102(30):10604–9.

    Article  PubMed  CAS  Google Scholar 

  30. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148–59.

    Article  PubMed  CAS  Google Scholar 

  31. Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer. 2007;120(Suppl 12):1–39.

    Article  PubMed  Google Scholar 

  32. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.

    Article  PubMed  CAS  Google Scholar 

  33. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med. 2003;349(14):1324–32.

    Article  PubMed  CAS  Google Scholar 

  34. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–20.

    Article  PubMed  CAS  Google Scholar 

  35. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976;17(1):1–7.

    Article  PubMed  CAS  Google Scholar 

  36. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2(8256):1129–33.

    Google Scholar 

  37. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2(8670):1004–6.

    Article  PubMed  CAS  Google Scholar 

  38. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex? Autoimmun Rev. 2008;7(8):626–30.

    Article  PubMed  CAS  Google Scholar 

  39. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008;8(9):737–44.

    Article  PubMed  CAS  Google Scholar 

  40. Inman RD. Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthr Rheum. 1978;21(7):849–52.

    Article  CAS  Google Scholar 

  41. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst. 1994;86(6):455–60.

    Article  PubMed  CAS  Google Scholar 

  42. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med. 1988;319(16):1047–52.

    Article  PubMed  CAS  Google Scholar 

  43. Hercberg S, Estaquio C, Czernichow S, et al. Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr. 2005;135(11):2664–8.

    Google Scholar 

  44. Edgren G, Nyren O, Melbye M. Cancer as a ferrotoxic disease: are we getting hard stainless evidence? J Natl Cancer Inst. 2008;100(14):976–7.

    Article  PubMed  Google Scholar 

  45. Edgren G, Reilly M, Hjalgrim H, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008;100(8):572–9.

    Article  PubMed  Google Scholar 

  46. Beard JL, Dawson H, Pinero DJ. Iron metabolism: a comprehensive review. Nutr Rev. 1996;54(10):295–317.

    Article  PubMed  CAS  Google Scholar 

  47. Stevens RG. Iron and the risk of cancer. Med Oncol Tumor Pharmacother. 1990;7(2–3):177–81.

    PubMed  CAS  Google Scholar 

  48. Zacharski LR, Chow BK, Howes PS, et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA. 2007;297(6):603–10.

    Article  PubMed  CAS  Google Scholar 

  49. Zacharski LR, Chow BK, Howes PS, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008;100(14):996–1002.

    Article  PubMed  CAS  Google Scholar 

  50. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337(19):1350–8.

    Article  PubMed  CAS  Google Scholar 

  51. Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007;8(4):311–6.

    Article  PubMed  Google Scholar 

  52. Fraumeni JF Jr. Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res. 1975;35(11 Pt. 2):3437–46.

    Google Scholar 

  53. Tazuma S. Gallstone disease: epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 2006;20(6):1075–83.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Prof. Georg Klein and Dr. Min-Han Tan for their critical review of an earlier draft of this manuscript. All four authors contributed to the study design and drafting of the manuscript. Dr Edgren had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The final approval of the manuscript was performed by Drs Edgren and Chang. Dr Edgren has received funding through a post-doctoral stipend from Svenska Sällskapet för Medicinsk Forskning (SSMF). No other funding was obtained for this study.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gustaf Edgren.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 12,662 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edgren, G., Liang, L., Adami, HO. et al. Enigmatic sex disparities in cancer incidence. Eur J Epidemiol 27, 187–196 (2012). https://doi.org/10.1007/s10654-011-9647-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-011-9647-5

Keywords

Navigation